Drug Pipeline

Bosutinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04877522 Asciminib Roll-over Study Chronic Myelogenous Leukemia Recruiting
Phase 3
NCT04971226 A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+… Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Active, Not Recruiting
Phase 2
NCT03297606 Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) Lymphoma, Non-Hodgkin Recruiting
Sponsors Running Bosutinib Trials
Novartis Pharmaceuticals (2) Canadian Cancer Trials Group (1)
Disease Areas
Leukemia (2) Multiple Myeloma (1) Chronic Myeloid Leukemia (CML) (1)
Get alerts when Bosutinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free